OA10568A - Rapid diagnostic procedure for ivermectin resistance - Google Patents
Rapid diagnostic procedure for ivermectin resistance Download PDFInfo
- Publication number
- OA10568A OA10568A OA60741A OA60741A OA10568A OA 10568 A OA10568 A OA 10568A OA 60741 A OA60741 A OA 60741A OA 60741 A OA60741 A OA 60741A OA 10568 A OA10568 A OA 10568A
- Authority
- OA
- OAPI
- Prior art keywords
- dye
- résistance
- ivermectin
- nematode
- nematodes
- Prior art date
Links
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 title claims abstract description 56
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 title claims abstract description 55
- 229960002418 ivermectin Drugs 0.000 title claims abstract description 55
- 238000002405 diagnostic procedure Methods 0.000 title abstract description 5
- 241000244206 Nematoda Species 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 24
- 210000001044 sensory neuron Anatomy 0.000 claims abstract description 23
- 239000012528 membrane Substances 0.000 claims abstract description 15
- 230000003071 parasitic effect Effects 0.000 claims abstract description 14
- 210000004222 sensilla Anatomy 0.000 claims abstract description 14
- 239000005660 Abamectin Substances 0.000 claims abstract description 12
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 claims abstract description 4
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 4
- 238000011534 incubation Methods 0.000 claims abstract 2
- 239000000975 dye Substances 0.000 claims description 23
- 238000010186 staining Methods 0.000 claims description 13
- 230000007547 defect Effects 0.000 claims description 12
- 241000243974 Haemonchus contortus Species 0.000 claims description 8
- GFZPJHFJZGRWMQ-UHFFFAOYSA-M diOC18(3) dye Chemical compound [O-]Cl(=O)(=O)=O.O1C2=CC=CC=C2[N+](CCCCCCCCCCCCCCCCCC)=C1C=CC=C1N(CCCCCCCCCCCCCCCCCC)C2=CC=CC=C2O1 GFZPJHFJZGRWMQ-UHFFFAOYSA-M 0.000 claims description 8
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 8
- 241000243985 Onchocerca volvulus Species 0.000 claims description 5
- 241000243988 Dirofilaria immitis Species 0.000 claims description 4
- 241000243796 Trichostrongylus colubriformis Species 0.000 claims description 4
- 210000002569 neuron Anatomy 0.000 claims description 4
- 238000009792 diffusion process Methods 0.000 claims description 3
- 229940099686 dirofilaria immitis Drugs 0.000 claims description 3
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims description 3
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 3
- 241000244188 Ascaris suum Species 0.000 claims description 2
- 241000244038 Brugia malayi Species 0.000 claims description 2
- 241001143352 Meloidogyne Species 0.000 claims description 2
- 241000243795 Ostertagia Species 0.000 claims description 2
- 241000244030 Toxocara canis Species 0.000 claims 1
- 241000244002 Wuchereria Species 0.000 claims 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 abstract description 7
- 238000012216 screening Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 14
- 239000003814 drug Substances 0.000 description 14
- 230000035772 mutation Effects 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 238000003745 diagnosis Methods 0.000 description 8
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 244000045947 parasite Species 0.000 description 6
- 241001494479 Pecora Species 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000000507 anthelmentic effect Effects 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 241000244201 Caenorhabditis briggsae Species 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000723 chemosensory effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000010196 hermaphroditism Effects 0.000 description 4
- 241000244203 Caenorhabditis elegans Species 0.000 description 3
- 206010034133 Pathogen resistance Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 230000001418 larval effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical class O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 244000183685 Citrus aurantium Species 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000243981 Onchocerca Species 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 229950008167 abamectin Drugs 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940124339 anthelmintic agent Drugs 0.000 description 2
- 239000000921 anthelmintic agent Substances 0.000 description 2
- 230000001679 anti-nematodal effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000035605 chemotaxis Effects 0.000 description 2
- 230000010159 dioecy Effects 0.000 description 2
- 230000001793 endectocide Effects 0.000 description 2
- 238000009830 intercalation Methods 0.000 description 2
- 230000002687 intercalation Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000000590 parasiticidal effect Effects 0.000 description 2
- 239000002297 parasiticide Substances 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 101800002638 Alpha-amanitin Proteins 0.000 description 1
- 241001156002 Anthonomus pomorum Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001441810 Caenorhabditis remanei Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000002163 Mesapamea fractilinea Species 0.000 description 1
- 241001494265 Onchocerca cervicalis Species 0.000 description 1
- 241000243987 Onchocerca gibsoni Species 0.000 description 1
- 241000244199 Panagrellus redivivus Species 0.000 description 1
- 241000498274 Pellioditis pellio Species 0.000 description 1
- 240000003085 Quassia amara Species 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- RXGJTYFDKOHJHK-UHFFFAOYSA-N S-deoxo-amaninamide Natural products CCC(C)C1NC(=O)CNC(=O)C2Cc3c(SCC(NC(=O)CNC1=O)C(=O)NC(CC(=O)N)C(=O)N4CC(O)CC4C(=O)NC(C(C)C(O)CO)C(=O)N2)[nH]c5ccccc35 RXGJTYFDKOHJHK-UHFFFAOYSA-N 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000191771 Teladorsagia circumcincta Species 0.000 description 1
- 241000243797 Trichostrongylus Species 0.000 description 1
- 241000244005 Wuchereria bancrofti Species 0.000 description 1
- 239000004007 alpha amanitin Substances 0.000 description 1
- CIORWBWIBBPXCG-SXZCQOKQSA-N alpha-amanitin Chemical compound O=C1N[C@@H](CC(N)=O)C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H]([C@@H](C)[C@@H](O)CO)C(=O)N[C@@H](C2)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@H]1C[S@@](=O)C1=C2C2=CC=C(O)C=C2N1 CIORWBWIBBPXCG-SXZCQOKQSA-N 0.000 description 1
- CIORWBWIBBPXCG-UHFFFAOYSA-N alpha-amanitin Natural products O=C1NC(CC(N)=O)C(=O)N2CC(O)CC2C(=O)NC(C(C)C(O)CO)C(=O)NC(C2)C(=O)NCC(=O)NC(C(C)CC)C(=O)NCC(=O)NC1CS(=O)C1=C2C2=CC=C(O)C=C2N1 CIORWBWIBBPXCG-UHFFFAOYSA-N 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 244000000054 animal parasite Species 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011981 development test Methods 0.000 description 1
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 description 1
- 229960003997 doramectin Drugs 0.000 description 1
- 244000078703 ectoparasite Species 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229940007210 ivomec Drugs 0.000 description 1
- 230000007653 larval development Effects 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100001225 mammalian toxicity Toxicity 0.000 description 1
- UHXUZOCRWCRNSJ-QPJJXVBHSA-N methomyl Chemical compound CNC(=O)O\N=C(/C)SC UHXUZOCRWCRNSJ-QPJJXVBHSA-N 0.000 description 1
- 229960001952 metrifonate Drugs 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 description 1
- 229960004816 moxidectin Drugs 0.000 description 1
- 230000001069 nematicidal effect Effects 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 208000003177 ocular onchocerciasis Diseases 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 1
- 239000000717 tumor promoter Substances 0.000 description 1
- 241001478887 unidentified soil bacteria Species 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 229960005502 α-amanitin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
- A61K49/0043—Fluorescein, used in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
- G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
- G01N2333/4353—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
- G01N2333/43534—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Optics & Photonics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biodiversity & Conservation Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Measurement Of Resistance Or Impedance (AREA)
- Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
- Thermistors And Varistors (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/071,251 US5583008A (en) | 1993-05-19 | 1993-05-19 | Rapid diagnostic procedure for ivermectin resistance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA10568A true OA10568A (en) | 2002-06-26 |
Family
ID=22100195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA60741A OA10568A (en) | 1993-05-19 | 1995-11-17 | Rapid diagnostic procedure for ivermectin resistance |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5583008A (de) |
| EP (1) | EP0698119B1 (de) |
| AU (1) | AU686178B2 (de) |
| CA (1) | CA2163204A1 (de) |
| DE (1) | DE69427858T2 (de) |
| NZ (1) | NZ267788A (de) |
| OA (1) | OA10568A (de) |
| WO (1) | WO1994026115A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6403308B1 (en) * | 1997-04-30 | 2002-06-11 | Mcgill University | Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| AU2001259169A1 (en) | 2000-04-26 | 2001-11-07 | Massachusetts Institute Of Technology | Cesert genes, proteins, and modulatory compounds |
| GB0012229D0 (en) * | 2000-05-19 | 2000-07-12 | Devgen Nv | Lipid uptake assays |
| US6790621B2 (en) * | 2001-01-12 | 2004-09-14 | Washington State University Research Foundation | Method of detecting ivermectin sensitivity in a canine subject by identifying a mutation in a mdr1-encoding sequence |
| CN101893570B (zh) * | 2010-03-24 | 2015-04-22 | 上海市农业技术推广服务中心 | 谷物类农产品中阿维菌素类农药多残留检测方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5124358A (en) * | 1990-01-16 | 1992-06-23 | The Board Of Reagents The University Of Texas System | Effect of transglutaminase inhibition on microfilariae development and macrofilariae viability |
| US5139948A (en) * | 1990-04-09 | 1992-08-18 | Merck & Co., Inc. | Strain of Trichostrongylus colubriformis with ivermectin and thiabendazole resistance |
| US5192546A (en) * | 1991-01-15 | 1993-03-09 | Mycogen Corporation | Synergistic pesticidal compositions |
| US5189026A (en) * | 1991-06-07 | 1993-02-23 | Fractal Laboratories, Inc. | Treatment of human diseases involving dysregulation or dysfunction of the nervous system |
-
1993
- 1993-05-19 US US08/071,251 patent/US5583008A/en not_active Expired - Fee Related
-
1994
- 1994-05-19 AU AU70189/94A patent/AU686178B2/en not_active Ceased
- 1994-05-19 DE DE69427858T patent/DE69427858T2/de not_active Expired - Fee Related
- 1994-05-19 EP EP94919151A patent/EP0698119B1/de not_active Expired - Lifetime
- 1994-05-19 CA CA002163204A patent/CA2163204A1/en not_active Abandoned
- 1994-05-19 WO PCT/US1994/005479 patent/WO1994026115A1/en active IP Right Grant
- 1994-05-19 NZ NZ267788A patent/NZ267788A/en unknown
-
1995
- 1995-11-17 OA OA60741A patent/OA10568A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0698119A4 (de) | 1997-08-27 |
| US5583008A (en) | 1996-12-10 |
| EP0698119B1 (de) | 2001-08-01 |
| CA2163204A1 (en) | 1994-11-24 |
| DE69427858D1 (de) | 2001-09-06 |
| AU686178B2 (en) | 1998-02-05 |
| EP0698119A1 (de) | 1996-02-28 |
| WO1994026115A1 (en) | 1994-11-24 |
| DE69427858T2 (de) | 2002-04-11 |
| NZ267788A (en) | 1997-11-24 |
| AU7018994A (en) | 1994-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Friedhoff | Transmission of babesia | |
| Coles | Anthelmintic resistance–looking to the future: a UK perspective | |
| Harris et al. | Killing of Gyrodactylus salaris (Platyhelminthes, Monogenea) mediated by host complement | |
| Troemel | Chemosensory signaling in C. elegans | |
| Aiken et al. | An epizootic and its decline of a blood fluke, Cardicola forsteri, in farmed southern bluefin tuna, Thunnus maccoyii | |
| Jarvi et al. | Validation of a death assay for Angiostrongylus cantonensis larvae (L3) using propidium iodide in a rat model (Rattus norvegicus) | |
| Guarneri et al. | Interaction of triatomines with their bacterial microbiota and trypanosomes | |
| US5583008A (en) | Rapid diagnostic procedure for ivermectin resistance | |
| AU2009262381B2 (en) | Method for characterising the biological activity of Helminth eggs, in particular Trichuris eggs | |
| Kent et al. | Important parasites of zebrafish in research facilities | |
| Várady et al. | In vitro characterization of lines of Oesophagostomum dentatum selected or not selected for resistance to pyrantel, levamisole and ivermectin | |
| Halton et al. | Trematode neurobiology | |
| Cook et al. | Nitric oxide production in celomocytes of the earthworm Eisenia hortensis following bacterial challenge | |
| Rufener et al. | Discovery and development of new antifilarial drugs (in vitro assays) | |
| Iliev et al. | Investigation on the benzimidazole resistance in gastrointestinal strongylids of sheep in southeastern Bulgaria | |
| Dolan et al. | Detection of changes occurring during recovery from the dauer stage in Heterorhabditis bacteriophora | |
| Fallon et al. | Effect of entomopathogenic nematodes on Plectrodera scalator (Fabricius)(Coleoptera: Cerambycidae) | |
| Zwanenburg | Sustainable control of gastrointestinal parasite infections in ruminants | |
| McCrea et al. | A novel assay to measure the emergence of third-stage filarial nematodes in individual mosquitoes | |
| McCrea et al. | A novel assay to isolate and quantify third-stage filarial larvae emerging from individual mosquitoes | |
| 菅原賢也 et al. | Studies on Bioactivity and Molecular Mechanism of Bifidobacterium longum on Anti-aging in Caenorhabditis elegans | |
| Dumidae et al. | Molluscicidal property of symbiotic bacteria associated with entomopathogenic nematodes against Indoplanorbis exustus and Radix rubiginosa, the intermediate hosts of trematode parasites | |
| Jenkins et al. | Fasciola hepatica in vitro: increased susceptibility to fasciolicides in a defined serum-free medium | |
| HOTEL et al. | NEW ZEALAND SOCIETY FOR PARASITOLOGY ANNUAL MEETING No. 46 25-26 OCTOBER 2018 | |
| Kaduková et al. | Comparison of the Efficiency of Diagnostic Tests Used to Prove Giardiasis in Terms of their Practicality and Use in the Veterinary Clinical Practice |